Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than ...

O 15, 2025, Barclays analyst Luke Sergott raised the price target for TXG from $17 to $22 while maintaining an Overweight ...

10x Genomics reported 18% YoY revenue growth in Q4, reaching $184M, with instruments revenue seeing a remarkable surge of 71%. The company celebrated the successful launch of its cutting-edge platform ...

Fintel reports that on December 22, 2025, Canaccord Genuity maintained coverage of 10x Genomics (NasdaqGS:TXG) with a Buy recommendation. Analyst Price Forecast Suggests 3.60% Upside As of December 21 ...

10x Genomics has been on my Compounding Healthcare “Bio Boom” speculative portfolio watch list since its IPO back in 2019. I believe 10x Genomics is becoming an entrenched name. After performing some ...

PLEASANTON, Calif., Jan. 21, 2022 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the expansion of its 10x ...

What Happened? Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 4.8% in the morning session after Canaccord Genuity maintained its 'Buy' rating and raised its price target on the company's ...

Forbes contributors publish independent expert analyses and insights. Steven covers accessibility and assistive technologies. Aug 07, 2023, 01:54pm EDT Aug 07, 2023, 03:58pm EDT This article is more ...

Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 6% in the morning session after BofA Securities maintained its "Buy" rating on the stock, even while lowering its price target. The firm ...

PLEASANTON — 10x Genomics has crafted plans for a major expansion of its Pleasanton operations through the purchase of a big property that it will develop as a modern campus, the biotech company said ...

(Reuters) - Gene-sequencing company 10x Genomics Inc sued startup Parse Biosciences Inc in Delaware federal court Wednesday, alleging its gene-analysis kits infringe patents related to 10x's Chromium ...

10x Genomics (NASDAQ: TXG), a biotechnology company that designs and manufactures gene sequencing technology, was listed following its IPO in September. While the stock saw some volatility post its ...